Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPN1 | P18031 | 8/20 | 0.42 |
| ▸ | BACE1 | P56817 | 1/20 | 0.41 |
| ▸ | MDM4 | O15151 | 1/20 | 0.38 |
| ▸ | TP53 | P04637 | 1/20 | 0.38 |
| ▸ | GRB2 | P62993 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17182790 | 0.92 | MDM4 (0.40) | PTPN1BACE1MDM4TP53 | |
| SCHEMBL17182771 | 0.91 | PTPN1 (0.42) | PTPN1BACE1MDM4TP53GRB2 | |
| SCHEMBL15690950 | 0.90 | BACE1 (0.48) | BACE1MDM4TP53 | |
| SCHEMBL17182788 | 0.80 | MDM4 (0.54) | BACE1MDM4TP53 | |
| SCHEMBL17182784 | 0.80 | MDM4 (0.54) | BACE1MDM4TP53 | |
| SCHEMBL7902079 | 0.79 | PTPN1 (0.51) | PTPN1MDM4TP53GRB2 | |
| SCHEMBL17182792 | 0.78 | BACE1 (0.44) | BACE1MDM4TP53 | |
| SCHEMBL7261546 | 0.78 | PTPN1 (0.49) | PTPN1MDM4TP53GRB2 | |
| SCHEMBL29401272 | 0.74 | MDM4 (0.52) | PTPN1MDM4TP53 | |
| SCHEMBL120691 | 0.74 | MDM4 (0.52) | PTPN1MDM4TP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150297761-A1 | PEPTIDIC STRUCTURES INCORPORATING AN AMINO ACID METAL COMPLEX AND APPLICATIONS IN MAGNETIC RESONANCE IMAGING | NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR | 2015-10-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150297761-A1 | PEPTIDIC STRUCTURES INCORPORATING AN AMINO ACID METAL COMPLEX AND APPLICATIONS IN MAGNETIC RESONANCE IMAGING | ARGLU1, CA1, SSTR3 | PTPN1 3585/4885BACE1 4752/4885MDM4 1751/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.